COVID drug fails to beat placebo in major trial
KEY POINTS
- An antiviral used to treat COVID-19 was found to do no better than a placebo in a British study.
- The drug, known as molnupiravir or Lagevrio, is prescribed to people at high risk of serious illness.
- The […]